Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5626_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •List of Contributors
- •Preface
- •1.2.4 Ancient Egypt
- •1.2.5 The Greeks
- •1.2.6 Arabic and Islamic Region
- •1.3 Development of Pharmacognosy in the Modern Era
- •1.4 The Relevance of Pharmacognosy in Pharmacological Research on Herbal Medicinal Products
- •1.5 Taxonomy and Botanical Authenticity
- •1.5.1 Plant Identification
- •1.5.2 Plant Nomenclature
- •1.5.3 Plant Classification
- •1.6 Phytochemistry – An Expanded Role in Traditional Medicine (History and Progress in Drug Discovery)
- •1.7 Recent Progress in Pharmacognosy and Phytochemistry
- •1.7.1 Bioactivity-guided Fractionation
- •1.7.2 Identification of Bioactive Compounds from Adulterants
- •1. Historical Overview of Pharmacognosy and Phytochemistry
- •1.1 Introduction to Pharmacognosy
- •1.2 Historical Development of Pharmacognosy
- •1.2.1 Mesopotamia Region
- •1.2.2 China
- •1.2.3 India
- •1.7.3 Omics Approach
- •1.7.4 Phytopharmacology and Mechanistic Studies
- •1.7.5 Multitargeted Approaches
- •1.7.6 Bioavailability and Drug Delivery Systems
- •1.7.7 Computational Approaches
- •1.7.8 Standardization and Quality Control
- •1.7.9 Nutraceuticals and Functional Foods
- •1.7.10 Sustainability and Conservation
- •1.7.11 Microbial Interactions and Co-cultivation
- •1.7.12 Biotechnological Approaches
- •1.7.13 Green Extraction Technology
- •1.7.14 Big Data and Artificial Intelligence
- •1.8 Conclusion
- •References
- •2. Classification of Crude Drugs of Natural Origin
- •2.1 Introduction
- •2.1.1 Definition of Crude Drugs
- •2.1.2 Importance of Classification of Crude Drugs
- •2.1.3 Early Attempts at Classification of Crude Drugs
- •2.2 Botanical Classification
- •2.2.1 Division Based on Plant Families
- •2.2.2 Importance of Taxonomy in Identifying and Categorizing Crude Drugs
- •2.2.3 Examples of Common Plant Families and Their Medicinal Representatives
- •2.3 Morphological Classification
- •2.3.1 Division Based on Plant Parts Used for Medicinal Purposes
- •2.3.1.1 Leaves
- •2.3.1.2 Roots
- •2.3.1.3 Stems
- •2.3.1.4 Bark
- •2.3.1.5 Flowers
- •2.3.1.6 Fruits
- •2.3.1.7 Seeds
- •2.3.2 Examination of Macroscopic and Microscopic Characteristics for Identification
- •2.3.3 Importance of Organoleptic Properties in Morphological Classification
- •2.4 Chemical Classification
- •2.4.1 Division Based on the Primary Active Chemical Constituents and Major Classes
- •2.4.1.1 Alkaloids
- •2.4.1.2 Glycosides
- •2.4.1.3 Volatile oils/terpenoids
- •2.4.1.4 Phenolic compounds
- •2.5 Pharmacological Classification
- •2.5.2 Relationship Between Pharmacological Activities and Chemical Constituents
- •2.6 Taxonomical Classification
- •2.6.1 Plant-Based Crude Drugs
- •2.6.2 Animal-Based Crude Drugs
- •2.6.3 Mineral-Based Crude Drugs
- •2.7 Chemotaxonomical Classification
- •2.7.1 Understanding of Chemotaxonomy
- •2.7.2 Chemotaxonomical Classes of Crude Drugs
- •2.7.2.1 Alkaloids
- •2.7.2.2 Flavonoids
- •2.7.2.3 Terpenoids
- •2.7.2.4 Phenolic Compounds
- •2.7.2.5 Glucosinolates
- •2.8 Geographical Classification
- •2.8.1 Division Based on the Geographic Origin of Crude Drugs
- •2.8.1.1 Tropical Drugs
- •2.8.1.2 Temperate Drugs
- •2.8.1.3 Arctic and Alpine Drugs
- •2.8.1.4 African Drugs
- •2.8.2 Influence of Climate, Soil, and Environmental Factors on Medicinal Properties
- •2.8.3 Examples of Region-specific Crude Drugs and Their Uses
- •2.9 Traditional and Cultural Classification
- •2.9.1 Division Based on Traditional Medicine Systems
- •2.9.2 Preservation of Traditional Knowledge in Classifying Crude Drugs
- •2.10 Modern Analytical Techniques in Classification
- •2.10.1 Use of Advanced Analytical Methods
- •2.10.1.1 Infrared Spectroscopy
- •2.10.1.2 Atomic Absorption Spectrometry
- •2.10.1.3 Inductively Coupled Plasma Mass Spectrometry
- •2.10.1.4 Chromatography Techniques
- •2.11.1.3 Taxonomic Bias and Expertise
- •2.11.2 Ethical Considerations in Classifying Endangered Plant Species
- •2.11.2.1 Data Accessibility and Accuracy
- •2.11.2.2 Taxonomic Uncertainties
- •2.11.2.3 Inadequate Resources for Research
- •2.11.2.4 Conservation Prioritization
- •2.11.2.5 Ex Situ Conservation and Access to Genetic Resources
- •2.11.2.6 Cultural and Traditional Knowledge
- •2.12 Future Perspectives
- •2.12.1 Integration of Traditional and Modern Classification Approaches for Crude Drugs
- •2.12.1.1 Incorporating Traditional Classification Systems
- •2.12.1.2 Analyzing Chemical Composition and Pharmacology
- •2.12.1.3 Bridging the Gap
- •2.12.1.4 Safety and Regulation
- •2.12.1.5 Research and Innovation
- •2.12.1.6 Holistic Patient Care
- •2.12.2 Role of Artificial Intelligence and Machine Learning
- •2.12.2.1 Data Analysis and Pattern Recognition
- •2.12.2.2 Predictive Modeling
- •2.12.2.3 Drug–Drug Interactions and Safety
- •2.12.2.4 Quality Control
- •2.12.2.5 Data Integration and Literature Mining
- •2.12.3 Emerging Trends and Innovations in the Field
- •2.13 Conclusion
- •2.13.1 Recapitulation of the Significance of Classification in Understanding Crude drugs
- •2.13.2 Importance of Accurate Classification of Crude Drugs for Safe and Effective Use in Medicine
- •2.13.3 Call to Further Research and Collaboration in Advancing Crude Drug Classification
- •References
- •2.10.2 Role of DNA Barcoding in Accurate Identification and Classification
- •2.10.3 Advantages and Challenges of Modern Techniques
- •2.11 Challenges in Classification
- •2.11.1 Overlapping Chemical Constituents in Different Classes
- •2.11.1.1 Polyploidy and Hybridization
- •2.11.1.2 Rapid Evolution and Speciation
- •3. Folk Medicine as a Source of Therapeutically Important Drugs: Evidence from Ethnobotanical Investigations
- •3.1 Introduction
- •3.1.1 Market Potential of Herbal Medicines
- •3.1.2 Early Records of Folk Medicine
- •3.1.3 Origin and Definition of Ethnobotany
- •3.1.4 History of Ethnobotany
- •3.1.5 Subdisciplines of Ethnobotany
- •3.2 Traditional Medical Systems
- •3.2.1 African Traditional Medicine
- •3.2.2 American Traditional Medicine (North, Central, and South)
- •3.2.3 Australian and Southeast Asian Medicine
- •3.2.4 Ayurvedic Medicine (Indian Traditional Medicine)
- •3.2.5 Chinese Traditional Medicine
- •3.2.6 European Medicine
- •3.2.7 Classical Arabic, North African Traditional Medicine
- •3.3 Importance of Ethnobotanical Research in Drug Discovery
- •3.4 Biological Activity of Medicinal Plants
- •3.4.1 Anticancer Activity
- •3.4.2 Antidiabetic Activity
- •3.4.3 Gastrointestinal Disorders
- •3.4.4 Respiratory Disorders
- •3.4.5 Antiviral Activity
- •3.4.6 Anti-inflammatory Activity
- •Acknowledgments
- •References
- •4. Complementary and Alternative Medicinal Systems
- •4.1 Introduction
- •4.2 Ayurveda System
- •4.2.1 History of Ayurveda
- •4.2.2 Principles of Ayurveda
- •4.2.2.1 Panchamahabhuta Siddhanta
- •4.2.2.2 Tridosha
- •4.2.2.3 Dhatus
- •4.2.2.4 Upadhatus
- •4.2.2.5 Malas
- •4.2.2.6 Srotas
- •4.2.2.7 Agni
- •4.2.2.8 Prakriti
- •4.2.3 Ayurvedic Methods of Diagnosis
- •4.2.3.1 Ayurvedic Treatment
- •4.2.4 Ayurvedic Formulations
- •4.3 Unani System
- •4.3.1 History of Unani System
- •4.3.2 Principles of Unani
- •4.3.3 Methods of Diagnosis
- •4.3.4 Treatment
- •4.3.4.1 Ilaj-Bil-Tadbeer (Regimental Therapy)
- •4.3.4.2 Ilaj-Bil-Dawa (Pharmacotherapy)
- •4.3.4.3 Ilaj-Bil-Yad (Surgical therapy)
- •4.3.5 Unani Formulations
- •4.4 Siddha System
- •4.4.1 History
- •4.4.2 Principles of Siddha
- •4.4.2.1 Five Elements
- •4.4.2.2 Seven Physical Constituents
- •4.4.2.3 Humours (Uyir Thathukkal)
- •4.4.2.4 Vaatham (Vali)
- •4.4.2.5 Pitham (Azhal)
- •4.4.2.6 Kapham (Aiyaam)
- •4.4.3 Methods of Diagnosis
- •4.4.3.1 Physical Examination of Urine
- •4.4.3.2 Pulse
- •4.4.3.3 Wrist Circumferential Sign
- •4.4.4 Treatment
- •4.4.5 Siddha Formulations
- •4.5 Homeopathy System
- •4.5.1 History
- •4.5.2 Principles of Homeopathy
- •4.5.3 Methods of Diagnosis and Treatment
- •4.6 Conclusion
- •References
- •5. Cultivation, Collection, and Preparation of Plant Drugs
- •5.1 History
- •5.2 Cultivation
- •5.2.1 Need of Medicinal Plants Cultivation
- •5.2.2 Limitation of Cultivation
- •5.2.3 Types of Cultivations
- •5.2.3.1 Sexual Propagation
- •5.2.3.2 Asexual Propagation
- •5.3 Factors Affecting Cultivation
- •5.3.1 Soil
- •5.3.2 Altitude, Temperature, and Humidity
- •5.3.3 Rainfall and Irrigation
- •5.3.4 Fertilizers and Manures in Plant Nutrition
- •5.3.5 Pests and Pest Control
- •5.3.6 Pest Control
- •5.3.6.1 Natural Method
- •5.3.6.4 Chemical Methods
- •5.4 Good Agricultural Practice
- •5.4.1 Objectives
- •5.4.2 Identification/Authentication of Cultivated Medicinal Plants
- •5.4.2.1 Medicinal Plants Selection
- •5.4.2.2 Botanical Identity
- •5.4.2.3 Specimens
- •5.4.3 Seeds and Other Propagation Materials
- •5.4.4 Site Selection
- •5.4.5 Soil
- •5.4.6 Fertilizers and Manures
- •5.4.7 Climate
- •5.4.8 Irrigation and Drainage
- •5.4.9 Plant Maintenance and Protection
- •5.4.10 Harvest
- •5.5 Good Collection Practices for Medicinal Plants
- •5.5.1 Collection Permissions
- •5.5.2 Technical Planning
- •5.5.3 Social and Ecological Impact
- •5.5.4 Selection of Medicinal Plants for Collection
- •5.6 Processing of Medicinal Plants
- •5.6.1 Primary Processing
- •5.6.2 Secondary Processing
- •5.6.2.1 Cutting/sectioning
- •5.6.2.2 Aging/sweating
- •5.6.2.3 Baking/roasting
- •5.6.2.4 Boiling/steaming
- •5.6.2.5 Stir-frying
- •5.7 Storage and Packaging
- •5.8 Sample Record for Cultivated Medicinal Plants
- •5.9 Voluntary Certification Scheme for Medicinal Plant Produce in Indian Scenario
- •5.9.1 Certification Process: For individual farmer/collector
- •References
- •6. Adulteration and Evaluation of Crude Drugs of Natural Origin
- •6.1 Introduction
- •6.2 Adulteration of Herbal Drugs
- •6.2.1 Poisonous or Deleterious Substances
- •6.2.1.1 Types of Poisonous or Deleterious Adulterants
- •6.2.2 Filth and Foreign Matter of Adulteration
- •6.2.2.1 Types and Examples
- •6.2.3 Microbiological Contamination
- •6.2.3.1 Examples of Microbiological Contamination
- •6.3 Types of Adulteration
- •6.3.1 Intentional/Deliberate Adulteration
- •6.3.2 Unknown or Incidental Adulteration
- •6.3.3 Metallic Contamination
- •6.3.4 Adulteration in Synthetic and Artificial Substances
- •6.4 Adulteration in Medicinal Plants
- •6.4.1 Reasons for Adulteration
- •6.4.2 Adulteration Caused Because of the Similar Morphology
- •6.4.3 Adulteration Caused Because of Confusion in Vernacular Names
- •6.4.4 Insufficient Basic Understanding of the Real Plant Source
- •6.5 Methods of Detection of Adulterants and Evaluation of Medicinal Herbs
- •6.5.1 Taxonomic Deciding Adulteration of Medicinal Plants
- •6.5.2 Morphological Analysis
- •6.5.3 Microscopic Analysis
- •6.5.4 Organoleptic Analysis
- •6.5.5 Qualitative and Quantitative of Phytochemical for Detection of Contaminants
- •6.5.6 Establishment of Fingerprint Profiles
- •6.5.7 Multiple Marker-based Fingerprint Profiles for Detection of Adulterants
- •6.6 Analytical Techniques in the Detection and Evaluation of Adulterants
- •6.6.1 Microscopy
- •6.6.2 Chromatographic Techniques
- •6.6.2.1 Thin-layer Chromatography
- •6.6.2.2 High-performance Liquid Chromatography
- •6.6.2.3 Gas Chromatography
- •6.6.3 Hyphenated Techniques
- •6.6.3.1 Gas Chromatography-mass Spectrometry
- •6.6.3.2 Liquid Chromatography-mass Spectrometry
- •6.6.4 Spectroscopic Methods
- •6.6.4.1 Nuclear Magnetic Resonance Spectroscopy
- •6.6.4.2 Mass Spectrometry
- •6.7 Challenges in Detection of Adulterants
- •6.8 Conclusion and Future Perspectives
- •References
- •7. Methods of Extraction
- •7.1 Introduction
- •7.2 Ideal Properties of Solvent
- •7.3 Solvents for Extraction
- •7.4 Factor Affecting Extraction Methods
- •7.5 Mechanism of Extraction
- •7.6 Methods of Extraction
- •7.6.1 Decoction
- •7.6.2 Maceration
- •7.6.2.1 Modified Macerations
- •7.6.3 Percolation
- •7.6.3.1 Imbibition
- •7.6.3.2 Maceration
- •7.6.3.3 Percolation
- •7.6.4 Soxhlation (Hot Continuous Percolation)
- •7.6.5 Extraction of Essential Oil Techniques
- •7.6.5.1 Distillation
- •7.6.5.1.1 Disadvantages of Hydro Distillation
- •7.6.5.1.2 Hydro Steam Distillation
- •7.6.5.1.3 Advantages of Hydro and Steam Distillation over Hydro Distillation
- •7.6.5.1.4 Disadvantages of Hydro and Steam Distillation over Water Distillation
- •7.6.5.1.5 Direct Steam Distillation
- •7.6.5.2 Expression
- •7.6.5.3 Ecuelle
- •7.6.5.4 Enfleurage
- •7.6.5.5 Hot Maceration Process/Digestion
- •7.6.5.6 Pneumatic Method
- •7.6.6 Phytonics
- •7.6.7 Pressurized Liquid Extraction/Accelerated Solvent Extraction
- •7.6.8 Pulsed Electric Field Extraction
- •7.6.9 Ultrasound-assisted Extraction
- •7.6.10 Microwave-assisted Extraction
- •7.6.11 Supercritical Fluid Extraction
- •References
- •8. Qualitative and Quantitative Methods of Phytochemical Analysis
- •8.1 Introduction
- •8.2 Phytochemical Screening Through Chemical Test
- •8.2.1 Alkaloids
- •8.2.2 Glycosides
- •8.2.3 Flavanoids
- •8.2.4 Tannins
- •8.2.5 Saponins
- •8.2.6 Terpenoids
- •8.2.7 Carbohydrates
- •8.3 Quantitative Methods of Phytochemical Analysis
- •8.3.1 Determination of total phenolic content
- •8.3.1.1 Folin-Ciocalteu Method
- •8.3.2 Determination of Total Flavonoid Content
- •8.3.2.1 Determination of Tannins
- •8.3.2.2 Estimation of Total Tannin Content
- •8.3.2.3 Determination of Total Alkaloid
- •8.3.2.4 Determination of Carbohydrates
- •8.3.2.5 Determination of Protein
- •8.3.3 Analytical Parameters for Fixed Oils and Waxes
- •8.4 Analytical Techniques In Phytochemical Analysis
- •8.5 Conclusion
- •References
- •9. Modern Analytical Techniques for Quality Control and Chemical Identification of Phytochemicals
- •9.1 Introduction
- •9.1.1 Background and Significance of Phytochemicals
- •9.1.2 Importance of Quality Control and Chemical Identification
- •9.1.3 Overview of Modern Analytical Techniques
- •9.2 Chromatographic Techniques
- •9.2.1 High-performance Liquid Chromatography
- •9.2.2 Gas Chromatography
- •9.2.3 Thin-layer Chromatography and High-performance Thin-layer Chromatography
- •9.3 Spectroscopic Techniques
- •9.3.1 Ultraviolet-visible Spectroscopy
- •9.3.2 Fourier Transform Infrared Spectroscopy
- •9.3.3 Nuclear Magnetic Resonance
- •9.4 Mass Spectrometry
- •9.4.1 Structural Elucidation of Phytochemicals by Mass Spectrometry
- •9.4.2 Quantitative Analysis and Quality Control Measures
- •9.4.2.1 Quantitative Analysis for Phytochemicals
- •9.4.2.1.1 External Calibration
- •9.4.2.1.2 Internal Standardization
- •9.4.2.1.3 Isotope Dilution Analysis
- •9.4.2.2 Quality Control Measures for Phytochemicals
- •9.5 Hyphenated Techniques
- •9.5.1 LC-MS and GC-MS Applications in Phytochemical Analysis
- •9.5.2 LC-NMR-MS for Comprehensive Structural Elucidation
- •9.6 Chemometric Tools and Data Analysis
- •9.6.1 Multivariate Analysis Techniques and Quality Control and Pattern Recognition Methods
- •9.7 Advanced Technologies
- •9.7.1 Metabolomics in Phytochemical Analysis and Molecular Imaging Techniques
- •9.8 Challenges and Future Perspectives
- •9.8.1 Current Challenges in Phytochemical Analysis
- •9.8.2 Future Directions and Emerging Technologies
- •9.9 Conclusion
- •References
- •10. Classification and Therapeutic Applications of Plant Secondary Metabolites
- •10.1 Introduction
- •10.1.1 Types of PSMs
- •10.1.2 Functions of PSMs
- •10.2 Classification of PSMs
- •10.2.1 Alkaloids
- •10.2.2 Terpenoids
- •10.2.3 Phenolic Compounds
- •10.2.4 Glycosides
- •10.2.5 Tannins
- •10.2.6 Saponins
- •10.3 Biosynthetic Pathways
- •10.4 Environmental Factors Affecting PSMs
- •10.5 Genetic Factors Affecting PSMs
- •10.6 Role of Enzymes in Plant Secondary Metabolite Production
- •10.7 PSMs Therapeutic Applications
- •10.7.1 Antimicrobial Properties
- •10.7.2 Anticancer Potential
- •10.7.3 Anti-inflammatory and Immunomodulatory Effects
- •10.7.4 Neuroprotective and Cognitive Benefits
- •10.7.5 Cardiovascular Health Benefits
- •10.7.6 Antioxidant and Antiaging Effects
- •10.8 Safety and Toxicity Considerations
- •10.8.1 Plant Toxicity
- •10.8.2 Potential Health Risks
- •10.9 Standardization of Herbal Medicine Using PSMs
- •10.9.1 Methods Used for Standardization of Herbal Medicines
- •10.9.2 Obstacles in Standardizing Herbal Medicines Related to PSMs
- •10.9.3 Variations in PSMs that Affect the Standardization Process
- •10.10 Conclusion
- •References
- •11. Isolation, Fractionation, and Purification of Natural Products
- •11.1 Introduction
- •11.2 Extraction
- •11.2.1 Consideration for the Extraction
- •11.2.2 Factors Affecting Extraction
- •11.2.3 Selection of Appropriate Solvent for Extraction
- •11.3 Extraction Methods/Technique
- •11.3.1 Maceration
- •11.3.2 Percolation
- •11.3.3 Soxhlet Extraction
- •11.3.4 Supercritical Fluid Extraction
- •11.3.5 Microwave-assisted Extraction
- •11.3.6 Pressurized Liquid Extraction
- •11.3.7 Ultrasound-assisted Extraction
- •11.3.8 Extraction with Ionic liquids
- •11.3.9 Accelerated (Pressurized) Solvent Extraction
- •11.4 Fractionation Techniques
- •11.4.1 Liquid–Liquid Fractionation
- •11.4.2 Chromatographic Techniques
- •11.4.2.1 Column Chromatography
- •11.4.2.2 Thin Layer Chromatography
- •11.4.2.3 High-performance Liquid Chromatography
- •11.4.2.4 Vacuum Liquid Chromatography
- •11.4.3 With Advances in Fractionation Techniques to Isolate and Purify Natural Products (e.g. counter-current chromatography)
- •11.5 Purification
- •11.5.1 Importance and Goals of Purification
- •11.5.2 Crystallization, Distillation, and Sublimation
- •11.5.2.1 Crystallization
- •11.5.2.2 Distillation
- •11.5.2.3 Sublimation
- •11.5.3 Advanced Purification Techniques
- •11.5.3.1 Flash Chromatography
- •11.5.3.2 Preparative HPLC
- •References
- •12. Pharmacological Screening of Drugs from Natural Sources
- •12.1 Introduction
- •12.2 Pharmacological Approaches
- •12.2.1 Discovery of Biologically Active Compounds
- •12.2.2 Pharmacological Screening Methods
- •12.2.2.1 In vivo Models
- •12.2.2.1.1 Screening Models for Cardiovascular System Diseases
- •12.2.2.1.2 Screening Models for Nervous System Diseases
- •12.2.2.1.3 Screening Models for Respiratory System Diseases
- •12.2.2.1.4 Screening Models for Urinary System Diseases
- •12.2.2.1.5 Screening Models for Musculoskeletal Diseases
- •12.2.2.1.6 Screening Models for Digestive System Diseases
- •12.2.2.1.7 Screening Models for Metabolic Diseases
- •12.2.2.1.8 Screening Models for Cancer
- •12.2.2.1.9 Screening Models for Immunomodulatory Diseases
- •12.2.2.1.10 Screening Models for Ophthalmic Diseases
- •12.2.2.1.11 Screening Models for Anti-inflammatory Activity
- •12.2.2.1.13 Screening Models for Antipyretic Activity
- •12.2.2.1.14 Screening Models for Dermal Diseases
- •12.2.2.2 In Vitro Models
- •12.2.2.2.1 Isolated Organs
- •12.2.2.2.2 Culture Methods
- •12.2.2.2.3 Enzyme Inhibition and Receptor Binding Assay
- •12.3 Conclusion
- •References
- •13. Biosynthetic Pathways of Phytopharmaceuticals
- •13.1 Introduction
- •13.1.1 Biosynthetic Pathway
- •13.1.2 History
- •13.1.3 Gross Idea
- •13.1.4 Milestones
- •13.2 Introduction to Primary and Secondary Metabolites
- •13.2.1 Primary Metabolites
- •13.2.2 Roles and Significance
- •13.2.2.1 Primary Metabolites
- •13.2.2.2 Secondary Metabolites
- •13.3 General Metabolic/Synthetic Pathway Which Shows from CO2 to Different Primary and Secondary Metabolite Formation
- •13.4 Enzymes
- •13.4.1 Functions of Enzymes
- •13.4.2 Catalytic Mechanism
- •13.5 Role of Enzymes in Biosynthetic Pathways
- •13.5.1 Basic Metabolic Pathway and Their Utilization to Produce Secondary Metabolite
- •13.5.1.1 Basic Metabolic Pathways
- •13.5.1.2 Utilization for Secondary Metabolites
- •13.5.1.4 Keto-enol Tautomerism
- •13.6 Other Structural Modifications
- •13.6.1 Isomerization
- •13.6.2 Hydrogenation and Dehydrogenation
- •13.6.3 Ring-Opening and Ring-closing Reactions
- •13.6.4 Functional Group Inter-conversion
- •13.6.5 Modern Techniques in Structural Elucidation
- •13.6.6 Importance in Drug Design and Synthesis
- •13.6.7 Intermediates and End Products in Secondary Metabolic Pathways
- •13.6.8 Integration of Pathways
- •13.7 Shikimic Acid Pathway for Biosynthesis of Aromatic Amino Acids
- •13.10 Acetate Mevalonate Pathways for Biosynthesis of Fatty Acyl-CoA
- •References
- •14. Pharmaceutical Aids of Natural Origin
- •14.1 Introduction
- •14.2 Some Industrially Important Pharmaceutical Aids
- •14.2.1 Acacia Gum
- •14.2.2 Agar-agar
- •14.2.3 Albumin
- •14.2.4 Alginates
- •14.2.5 Anthocyanidins
- •14.2.6 Cellulose
- •14.2.7 Chitosan
- •14.2.8 Cochineal
- •14.2.9 Curcumin
- •14.2.10 Gelatin
- •14.2.11 Gellan Gum
- •14.2.12 Guar Gum
- •14.2.13 Gum Karaya
- •14.2.14 Gum Tragacanth
- •14.2.15 Inulin
- •14.2.16 Lawsone
- •14.2.17 Locust Bean Gum
- •14.2.18 Pectins
- •14.2.19 Starch
- •14.2.20 Tamarind Gum
- •14.2.21 Xanthan Gum
- •14.3 Conclusion
- •References
- •15. Nutraceuticals and Cosmeceuticals
- •15.1.1 Definition of Nutraceuticals and Cosmeceuticals
- •15.1.2 Historical Overview
- •15.1.3 Significance in Modern Healthcare and Beauty Industries
- •15.2 Nutraceuticals
- •15.2.1 Definition and Classification
- •15.2.1.1 Functional Foods
- •15.2.1.2 Dietary Supplements
- •15.2.2 Key Components and Ingredients
- •15.2.2.1 Vitamins and Minerals
- •15.2.2.2 Antioxidants
- •15.2.2.3 Omega-3 Fatty Acids
- •15.2.2.4 Probiotics
- •15.2.3 Health Benefits
- •15.2.3.1 Nutraceutical in Disease Prevention
- •15.2.3.2 Immune System Support
- •15.2.3.3 Cognitive Health
- •15.2.3.4 Anti-inflammatory Effects
- •15.3 Cosmeceuticals
- •15.3.1 Definition and Classification
- •15.3.1.1 Skin Cosmeceuticals
- •15.3.1.2 Creams Cosmeceuticals
- •15.3.1.3 Hair Cosmeceuticals
- •15.3.1.4 Antiaging Cosmeceuticals
- •15.3.2 Active Ingredients
- •15.3.2.1 Retinoid
- •15.3.2.2 Peptide
- •15.3.2.3 Hyaluronic Acid
- •15.3.2.4 α-Hydroxy Acids and β-Hydroxy Acids
- •15.3.3 Beauty and Dermatological Benefits
- •15.3.3.1 Wrinkle Reduction
- •15.3.3.2 Moisturization and Hydration
- •15.3.3.3 Sun Protection and Acne Management
- •15.4 Synergies Between Nutraceuticals and Cosmeceuticals
- •15.4.1 Nutraceutical and Cosmeceutical (Nutra-cosmetical)
- •15.4.2 Internal and External Approaches to Health and Beauty
- •15.4.3 Complementary Benefits
- •15.4.3.1 Skin Health from Within
- •15.4.3.2 Holistic Approaches to Beauty and Wellness
- •15.5 Regulatory Considerations
- •15.5.1 FDA Guidelines for Nutraceuticals
- •15.5.2 Cosmetic Regulations and Approvals
- •15.5.3 Challenges and Opportunities in Compliance
- •15.6 Future Trends and Innovations
- •15.6.1 Advances in Nutraceutical Research
- •15.6.2 Cutting-edge Cosmeceutical Technologies
- •15.6.3 Market Trends and Consumer Preferences
- •15.7 Conclusion
- •References
- •16. Pesticides and Allergens
- •16.1 Introduction
- •16.2 Natural Pesticide/Biopesticides and Natural Anti-allergens: Source, Bioactive Substances and Applications
- •16.2.1 Natural Pesticides/Biopesticides
- •16.2.1.1 Plant-based Biopesticides
- •16.2.1.2 Insect-based Biopesticides
- •16.2.1.3 Marine-based Biopesticides
- •16.2.1.4 Animal-based Biopesticides
- •16.2.1.5 Microorganism-based Biopesticides
- •16.2.2 Natural Anti-allergens
- •16.2.2.1 Plant-based Anti-allergens
- •16.2.2.2 Insect-based Anti-allergens
- •16.2.2.3 Marine-based Anti-allergens
- •16.2.2.4 Animal-based Anti-allergens
- •16.2.2.5 Microorganism-based Anti-allergens
- •16.3 Pharmacological Mechanism and Toxicity Profile of Some Common Natural Pesticides and Anti-allergens
- •16.3.1 Natural Pesticides or Biopesticides
- •16.3.1.1 Azadirachtin
- •16.3.1.2 Abamectin
- •16.3.1.3 Nicotine
- •16.3.1.4 Bacillus thuringiensis (Bt)
- •16.3.1.5 Ryania
- •16.3.1.6 Spinosad
- •16.3.1.7 Pyrethrins
- •16.3.1.8 Rotenone
- •16.3.2 Pharmacological Mechanism and Toxicity of Natural Anti-allergens
- •16.3.2.1 Tussilagone
- •16.3.2.2 Mangiferin
- •16.3.2.3 Shikonin
- •16.3.2.4 Okicamelliaside
- •16.4 Global Market Surveillance of Biopesticides and Anti-allergens
- •16.5 Commercial Production and Formulations of Natural Pesticides and Anti-allergens
- •16.5.1 Commercial Production of Natural Pesticides
- •16.6 Regulatory Aspects for Quality Control of Pesticides and Anti-allergens
- •16.6.1 Regulatory Standard for Pesticides
- •16.6.2 The Regulatory Standard for Anti-allergens
- •16.7 Future Prospects and Opportunities
- •Acknowledgments
- •Conflict of Interest
- •Funding
- •References
- •17. Comparative Phytochemistry and Chemotaxonomy
- •17.1 Introduction
- •17.2 Chemotaxonomy
- •17.3 Chemical Markers in Chemotaxonomy
- •17.3.1 Primary Metabolites
- •17.3.2 Secondary Metabolites
- •17.3.2.1 Glycosides
- •17.3.2.2 Alkaloids
- •17.3.2.3 Terpenoids
- •17.3.2.4 Phenolic Compounds
- •17.4 Methods in Chemotaxonomy
- •17.4.1 Chromatography
- •17.4.2 Spectroscopy
- •17.5 Phytochemical Approach in Chemotaxonomy
- •17.5.1 Fatty Acids
- •17.5.2 Alkaloids
- •17.5.3 Phenolic Compounds
- •17.5.4 Essential Oils
- •17.5.5 Glycosides
- •17.5.6 Lignans
- •17.6 Limitations of Chemotaxonomy
- •17.7 Conclusion
- •References
- •18. Medicinal Plant Biotechnology
- •18.1 Introduction
- •18.2 Plant Tissue Culture
- •18.2.1 History of Plant Cell Culture Technology
- •18.2.2 Nutritional Requirements and Cultural Media
- •18.2.3 Plant Tissue Culture Laboratory Requirements
- •18.2.4 Micropropagation
- •18.2.5 Types of Culture
- •18.2.6 Synthetic Seed or Artificial Seed
- •18.2.7 In-Vitro Plant Germplasm Conservation
- •18.2.8 Plant Cell Immobilization
- •18.2.8.1 Methods of Immobilization
- •18.2.9 Biotransformation
- •18.2.10 Applications of Plant Tissue Culture
- •18.3 Genetic Engineering (Recombinant DNA Technology)
- •18.3.1 Restriction Endonuclease
- •18.3.2 Vectors as Carriers of Transgene
- •18.3.3 Methods of Gene Transfer
- •18.3.3.1 Direct Gene Transfer Methods
- •18.3.3.2 Indirect Gene Transfer Methods
- •18.3.4 Applications of Genetic Engineering
- •18.4 Conclusion
- •References
- •19. Marine Pharmacognosy
- •19.1 Introduction
- •19.1.1 Exploring Marine Organisms for Bioactive Compounds
- •19.1.2 Importance of Marine Organism in Drug Discovery
- •19.2 Marine Ecosystems and Biodiversity
- •19.2.1 Types of Marine Ecosystems
- •19.2.2 Biodiversity in Marine Environments
- •19.2.3 Adaptations and Survival Strategies
- •19.2.4 Ecosystem Services Provided by Marine Biodiversity
- •19.2.5 Biodiversity Threats and Conservation
- •19.3 Bioactive Compounds from Marine Microorganisms
- •19.3.1 Microbial Diversity in the Marine Environment
- •19.3.2 Isolation and Characterization Techniques
- •19.3.3 Pharmaceutical Applications
- •19.4 Marine Algae and Their Medicinal Potential
- •19.4.1 Diversity of Marine Macroalgae
- •19.4.1.1 Cyanobacteria as Marine Microalgae
- •19.4.1.2 Marine Macroalgae
- •19.4.2 Bioactive Compounds and Their Applications
- •19.4.2.1 Pigments
- •19.4.2.1.1 Polyunsaturated Fatty Acids
- •19.4.2.2 Proteins
- •19.5 Marine Invertebrates and Its Bioactive
- •19.5.1 Sponges (Phylum Porifera)
- •19.5.2 Molluscs
- •19.5.3 Echinoderms
- •19.6 Extraction Process and Characterization Techniques
- •19.6.1 Collecting and Processing of Marine Compounds
- •19.6.2.1 Supercritical Water Extraction
- •19.6.2.2 Supercritical Fluid Extraction
- •19.6.2.3 Solid-phase Extraction
- •19.6.2.4 Microwave-assisted Extraction
- •19.6.3 Analytical Tools and Technologies
- •19.6.3.1 Biological Screening
- •19.6.3.2 Thin-layer Chromatography Analysis
- •19.6.3.3 Nuclear Magnetic Resonance Analysis
- •19.6.3.4 Mass Spectroscopy
- •19.7 Pharmacological Activities of Marine-derived Compounds
- •19.7.1 Anticancer Properties of Marine Compounds
- •19.7.1.1 Marine Plants
- •19.7.1.1.1 Macroalgae (Seaweed)
- •19.7.1.1.2 Microalgae
- •19.7.1.2 Marine Fungi
- •19.7.1.3 Marine Bacteria
- •19.7.1.4 Softcorals
- •19.7.2 Neuroprotective and Neuropharmacological Effects
- •19.7.2.1 Parkinson’s Disease
- •19.7.2.1.1 Fucoidan
- •19.7.2.1.2 Seaweeds
- •19.7.2.1.3 Astaxanthin
- •19.7.2.2 Alzheimer’s Disease
- •19.7.2.2.1 Hymenialdisine
- •19.7.2.2.2 Cerebrosides
- •19.8 Preclinical and Clinical Studies of Marine Microorganisms
- •19.8.1 Aplidin (Plitidepsin)
- •19.8.2 Bryostatin-1
- •19.8.3 Dolastatin 10 (IMMU-110)
- •19.8.4 Halaven (Eribulin)
- •19.8.5 Squalamine
- •19.8.6 Lurbinectedin
- •19.9 Marketed Marine Drug Product
- •19.10 Future Prospects
- •19.10.1 Advancements in Marine Natural Product Research
- •19.10.2 Overcoming Challenges in Sustainable Marine Development
- •19.11 Conclusion
- •References
- •20. Molecular Pharmacognosy
- •20.1 Introduction
- •20.1.1 History and Evolution of Pharmacognosy
- •20.1.2 Current Trends in Pharmacognosy
- •20.1.3 Scope and Objectives
- •20.2 Molecular Biology Techniques in Pharmacognosy
- •20.2.1 DNA Extraction, Polymerase Chain Reaction, Sequencing, and Cloning
- •20.2.2 Significance of Different Molecular Biology Techniques
- •20.3 Molecular Genetics and Genomics of Medicinal Plants
- •20.3.1 Genomics of Medicinal Plants
- •20.3.1.1 Genome Evolution
- •20.3.1.2 Genome Duplication
- •20.3.1.3 Examining the Molecular Genetic Basis for the Economic Features of Medicinal Herbs Using Whole Genome Sequences
- •20.3.1.4 Transcriptome Analysis
- •20.3.1.5 Case Studies of Herbal Genomics
- •20.3.2 Genetics
- •20.3.2.1 Novel Technologies in Genetics and Biotechnology to Evaluate Genetic Multiplicity and Analyze Genomic and Transcriptomic Data
- •20.4 PTC of Medicinal Plants
- •20.4.1 Direct Applications of PTC
- •20.4.1.1 Mass Propagation
- •20.4.1.2 Germplasm Conservation
- •20.4.1.3 Secondary Metabolite Production
- •20.4.1.4 Genetic Improvement
- •20.4.1.5 Accelerated Breeding Programs
- •20.4.2 Indirect Applications of Plant Tissue Culture
- •20.4.2.1 Ploidy Engineering
- •20.5 Molecular Biosynthesis and Metabolomics of Medicinal Plants
- •20.5.1 Importance and Application of Metabolomics in Medicinal Plant Research
- •20.5.2 Metabolomics Techniques and Analytical Tools
- •20.6 Molecular Pharmacology and Toxicology of Medicinal Plants
- •20.6.1 Pharmacology of Medicinal Plants
- •20.6.1.1 Phytochemical Analysis
- •20.6.1.2 Bioassays
- •20.6.1.3 Receptor Binding Studies
- •20.6.1.4 Pharmacodynamics, Pharmacokinetics, and Clinical Trials
- •20.6.2 Toxicology of Medicinal Plants
- •20.6.2.1 In Vivo Toxicity Studies
- •20.6.2.2 In Vitro Toxicity Assays
- •20.6.2.3 Safety Pharmacological Studies
- •20.6.2.4 Risk Assessment
- •20.7 Mechanism of Action, Efficacy, and Toxicity of Plant-derived Drugs
- •20.8 Conclusion and Future Prospects
- •References
- •21. Clinical Pharmacognosy
- •21.1 Introduction
- •21.2 Pharmacognosy
- •21.2.1 Emerging Areas in Pharmacognosy
- •21.2.1.1 Forensic Pharmacognosy
- •21.2.1.2 Molecular Pharmacognosy
- •21.2.1.3 Ecopharmacognosy
- •21.2.2 Function of Pharmacognosy in Healthcare System
- •21.3 Clinical Pharmacognosy
- •21.3.1 Role of Clinical Pharmacognosy in Healthcare System
- •21.3.2 Drug Interaction Studies on Botanicals and Dietary Supplements
- •21.3.2.1 Concept of Drug Interaction
- •21.3.2.1.1 Risk Factors for Drug Interactions
- •21.3.2.1.2 Effect of Dietary Supplements and Botanicals on Drug
- •21.3.2.1.3 Effect of Drugs on Dietary Supplements and Botanicals
- •21.3.2.2 Drug Interaction with Botanicals and Dietary Supplements
- •21.3.2.2.1 Examples of Drug Interaction with Botanicals and Dietary Supplements
- •21.3.3.1 Natural Allergenic Extracts: Production and Quality Control
- •21.3.3.2 Methods for the Quality Control of Allergenic Extracts with their Advantages and Disadvantages
- •21.3.3.3 Allergenic Extracts for Diagnosis and Treatment (Table 21.3)
- •21.4 Clinical Studies on Botanicals and Dietary Supplements
- •21.4.1 Phase I, II, III, and IV Trial on Botanicals, and Dietary Supplements with Example
- •21.5 Clinical Pharmacokinetics
- •21.5.1 Clinical Support of the Herbal-drug Interaction Caused by the Blockage of Transporters and Drug-metabolizing Enzymes
- •21.5.1.1 Hydrastis Canadensis
- •21.5.1.2 Kava Kava
- •21.6 Phytoequivalence
- •21.7 Future Prospects of Clinical Pharmacognosy
- •21.8 Conclusion
- •References
- •Index

Index 451
dopamine (DA), 240
double maceration, 209
Dragendorff’s test, 145–146
drainage of cultivated medicinal plants, 90
Dravaka, 71
drilling method, 84
Drosera, 338
Drosera adelae, 338
Drosera aliciae, 338
Drosera binata, 338
Drosera burmannii, 338
Drosera dielsiana, 338
Drosera hilaris, 338
Drosera montana, 338
Drosera petiolaris, 338
Drosera pygmaea, 338
Drosera spatulata, 338
drought-resistant plants, 87
drug delivery systems, 12
drug design, 264
drug discovery, ethnobotanical research in, 48–49
drug-drug interaction, 423
AI and ML in, 34
drug interaction studies on botanicals and dietary
supplements, 423
with botanicals and dietary supplements, 424–428
dietary supplements and botanicals on drug,
effect of, 424
herbs and, 428
risk factors for, 424
Drugs and Cosmetics Act 1940, 88
drying, of plant material, 93
duckweed (Lemna minor), 318
Dunaliella salina, 377
Dysphania ambrosioides (Mexican tea) extract, 318
e
Ebers Papyrus, 2
Echinacea purpurea, 300
Echinacea species, authentication of, 112
echinacoside, 341
Echinodermata Phylum, 379
echinoderms, 379–380, 379
Echinoidea, 379
ecopharmacognosy, 422
ecosystem services, by marine biodiversity, 373
Ecteinascidia turbinata, 378
ecuelle, 130–131, 131
Edible Oils Packaging (Regulation) Order of 1988, 306
E-guggulsterone, 3
Ehrlich’s test, 146
eicosapentaenoic acid (EPA), 299, 318, 377
electric light scattering (ELS), 9
electric shocks, 364
electrocardiograms (ECGs), 237–238
normal ECG of rat, 237
electrofusion, 358
electrolytes, 257
electron transport chain (ETC), 260
electrophoresis, 158–159
electroporation, 364
electrospray ionization (ESI), 382
elevated plus maze test, 240
elicitation, 361
elicitors, 361
ellagic acid, 308–309
embryo culture, 359
emollients, 18
emulsion test, 150
encapsulation, 360
endangered plant species
conservation prioritization, 33
cultural and traditional knowledge, 33
data accessibility and accuracy, 32
ethical considerations in, 32
ex situ conservation and access to genetic
resources, 33
inadequate resources for research, 33
taxonomic uncertainties, 32–33
endogenous elicitors, 361
endrin, 315
energy
efficiency of enzymes, 261
molecules, 257
enfleurage, 131, 131
enhanced solvent extraction system (ESE), 133
5-enolpyruvylshikimate-3-phosphate (EPSP), 265
entomopathogenic fungi, 318
entrapment, 360
environmental management, genetic engineering
applications in, 365
Environmental Protection Agency
(EPA), 318
enzymatic method, 357
enzyme-assisted extraction, 381–382
enzyme inhibition, 252, 410
enzyme-linked immunosorbent assay (ELISA),
159, 411
enzymes, 260
in biosynthetic pathways, 261–263
catalytic mechanism, 261
functions, 260–261
role in PSMs production, 195–196, 196
ephedra (Ma Huang), 428
Ephedra sinica, 20
ephedrine, 335
epicatechin gallate, 112
epigallocatechin gallate (EGCG), 112
Eribulin, 374
Eruca sativa, 336
erythromycin, 43, 258
Escherichia coli, 362

452 Index
essential oils, 340–341
distillation, 129–130
ecuelle, 130–131, 131
enfleurage, 131, 131
expression, 130
extraction of, 129
hot maceration process/digestion, 131–132
pneumatic method, 132, 132
esterification, 278
ethanol, 257, 279
ether, 124
ethnoalgology, 46
ethnoarchaeobotany, 46
ethnobotanical survey, 43
ethnobotany, 46
ethnobotanical research in drug discovery,
48–49
ethnomedicinal plants used in folk practices,
50–56
history of, 45
origin and definition of, 44–45
subdisciplines of, 45, 46
ethnobryology, 46
ethnoecology, 46
ethnogastrology, 46
ethnohorticulture, 46
ethnolichenology, 46
ethnomedicobotany, 46
ethnomusicology, 46
ethnopharmacognosy, 46
ethnopharmacology, 46
ethnophytotaxonomy, 46
ethnopteridology, 46
ethnoveterinary, 46
ethosomes, 310
ethyl acetate, 279
ethylene, 353
ethylene diamine tetra acetic acid (EDTA), 351
ethyl esters of n–3 fatty acids, 309
Eucalyptus, 20
Euphrasia, 338
Euphrasia nemorosa, 338
Euphrasia rostkoviana, 338
Euphrasia stricta, 338
European Food Safety Authority (EFSA), 305–306
European Medicinal Agency (EMA), 435
European medicine, 47
European Union law (EU law), 297
Eurotium, 321
evaporative light-scattering detector (ELSD), 224
exogenous elicitors, 361
expression vectors, 363
ex situ conservation, 405
external calibration, 180
extracellular matrix (ECM), 302
extracted ion chromatogram (XIC), 181
extraction, 121–122, 124, 208, 380–382
accelerated solvent extraction, 215
consideration for, 208
decoction, 125
of essential oil techniques, 129–132
factor affecting, 124, 208–209
ideal properties of solvent, 122–123
with ionic liquids, 214–215
maceration, 126, 209–210
mechanism of, 124–125
methods of, 125, 209
microwave-assisted extraction, 136–138, 213
percolation, 126–129, 210–211
phytonics, 132–133
pressurized liquid extraction, 213–214, 133–134
pulsed electric field extraction, 134–135
region-wise distribution of endemic species, 122
selection of appropriate solvent for, 209
solvents for, 123–124, 123, 123
Soxhlet extraction, 211–212
supercritical fluid extraction, 138–139, 212–213
ultrasound-assisted extraction, 135–136, 214
exudate gum, 281
f
Fabaceae, 18, 19
farnesyl pyrophosphate, 267
fatty acid methyl ester (FAME), 336
fatty acids (FAs), 257, 270, 336
fatty acid synthase (FAS), 269
initiation of, 270
fatty acyl CoA
acetate mevalonate pathways for biosynthesis of,
269–271, 270
formation of, 271
Fehling’s test, 149
ferric chloride test, 147
for tannins, 148
fertilization, 84
fertilizer
of cultivated medicinal plants, 90
in plant nutrition, 87
ferulic acid (FA), 182
Fick’s law, 209
Ficus deltoidea, 339
fingerprinting techniques, 12
fish oil, 320
five-element theory, 75–76
in Tholkappiyam, 75
flame ionization detector (FID), 171, 217
flame test, 150
flash chromatography, 224–225
flavonoids, 7, 8, 23, 144, 147–148, 189, 191, 200,
258, 308, 335, 337
chemotaxonomical classes of crude drugs, 26
glycosides, 22

Index 453
flavonol aglycones, 8
flaxseed (Linum usitatissimum), 21, 22
floral scent compounds, 259
flower bud culture, 358
flowers used for medicinal purposes, 20
fluorescein diacetate (FDA), 357
fluorescent lamps, 354
Folin-Ciocalteu assay, 151, 213
Folin-Ciocalteu method, 151, 152
folk medicine
early records of, 44
ethnomedicinal plants used in folk practices, 50–56
folk taxonomies, 334
folk therapy, 1
Food, Drug, and Cosmetic Act (FDCA), 425
food allergies, 430
Food and Agricultural Organization (FAO), 306
Food and Drug Administration Modernization
Act of 1997, 306
Food Safety and Standards Authority (FSSA), 306
Food Safety and Standards Authority of India
(FSSAI), 306
forensic genetics, 403
forensic pharmacognosy, 422
Fossilia, 333
Foundation for Innovation in Medicine (FIM), 297
Fourier transform infrared spectroscopy (FTIR spectroscopy),
175, 177
foxglove (Digitalis purpurea), 7, 22, 25, 36
fractionation techniques, 215
chromatographic techniques, 216–220
counter-current chromatography, 220–221
liquid–liquid fractionation, 216
methods used for separation of phytoconstituents,
220–221
free erythrocyte protoporphyrin (FEP), 148
free radicals, 299
French lilac plant (Galega officinalis L.), 7
friable callus, 356
froth test, 147
for saponins, 148–149
fructose-induced hypertension in rats, 236–237, 237
Fruit Products Order of 1955, 306
fruits, used for medicinal purposes, 20
fucoidan, 372, 383–384
functional foods, 13, 298–299
functional genomics, 404
functional group inter-conversion, 263
fundamental metabolism, 262
furano-cembranoids, 384
g
galactose, 275–276
galantamine, 1
Galega officinalis L.. see French lilac plant
(Galega officinalis L.)
gallic acid, 265–266
gallic acid equivalent (GAE), 210
γ-amino butyric acid (GABA), 321
γ-glutamyl transpeptidase (GTP), 321
gamma-linolenic acid (GLA), 300, 310
garbling process, 92
garlic (Allium sativum), 57, 426
allicin in, 309
with antioxidant potentials, 303
phenolic compounds extraction from, 211
reduces mortality in gastric cancer, 49
supplements, 426
used for treating cancer, 56
gas chromatography (GC), 30, 144, 219, 334, 410
in detection and evaluation of adulteration, 113
in estimation of phytochemicals, 171–173
in phytochemical analysis, 157
gas chromatography-mass spectrometry (GC-MS), 3, 101,
113, 217, 408
applications in phytochemical analysis, 180–181
authentication of Ginkgo biloba extract using, 113–114
in phytochemical analysis, 158
gas chromatography with flame ionization detection
(GCFID), 336
gas-liquid chromatography (GLC), 217, 335
gastrodin, 8
gastrointestinal disorders, of medicinal plants, 57–58
gastrointestinal tract (GI tract), 424
gedunin, 199
gelatin, 279
gellan gum, 279–280, 352
gelling agent, 352
gel matrixes, entrapment in, 360
gene duplication, 401
gene-editing tools, 328
gene transfer methods, 364
direct gene transfer methods, 364
indirect gene transfer methods, 364–365
generally recognized as safe (GRAS), 310, 425
genetically modified organisms (GMOs), 403
genetic engineering, 13, 256, 347, 362, 396
applications, 365
gene transfer methods, 364–365
restriction endonuclease, 362–363
vectors as carriers of transgene, 363
genetic improvement, 406
genetic map, 402
genetic markers, 110
genetics, 403
novel technologies in biotechnology and, 403–404
genistein, 8
genome duplication, 401
genome evolution, 401
genome-wide association studies (GWAS), 404
genomics, 11
genotoxicity studies, 411

454 Index
geographical classification, of crude drugs, 26
division based on geographic origin of crude drugs, 26–27
influence of climate, soil, and environmental factors on
medicinal properties, 27
region-specific crude drugs and uses, 27–28
geraniol synthase (GES), 404
Geranium, 341
Geranium carolinianum, 341
geranyl-eranyl pyrophosphate, 267
geranyl (geranyl) diphosphate synthase (G(G) PPS), 404
geranyl pyrophosphate, 267
germplasm, 359
conservation, 405–406
Ghrita, 71
Gibberella fujikuroi, 353
gibberellins (GAs), 353
ginger
in cardiovascular diseases, 309
in gastrointestinal disorders, 57–58
Gingidia, 340
Ginkgo biloba, 11, 20, 426
adulterants identification in extracts of, 111
chromatographic and spectral fingerprints for
identification of adulterated, 112
ginkgolic acids (GAs), 111
ginseng (Panax ginseng), 20, 28, 36, 111, 308, 426–427
Glehnia littoralis, 336
gluconeogenesis, 260
glucosinolates, 26, 189, 259
glutathione peroxidase (GPx), 198, 323
glyceraldehyde-3-phosphate (G3P), 260
glycine, 334–335
glycoalkaloids, 201
glycogen synthase kinase 3 (GSK3), 379
glycolysis, 260, 262
glycosides, 3, 144, 146–147, 192–193, 258–259, 334–335, 341
in crude drugs, 21, 22
glycosylates, 22
glycosylation, 277
glycosyltransferases (GTs), 192
glycosynthases, 192
glycyrrhetic acid, 427
Glycyrrhiza glabra (liquorice), 19, 44, 411
glycyrrhizic acid, 198
glycyrrhizin, 194, 427
Golden Age of Arabic Medicine, 2
good agricultural and collection practices (GACP), 89
good agricultural practices (GAP), 88
good field collection practices (GFCP), 97
good manufacturing practice (GMP), 308, 326, 429
gradient elution, 219, 220
graft copolymerization, 278
granules, 325
gravity column chromatography, 217–218
grease spot test, 150
Greeks, medicinal plant use in, 2
green chemistry principles, 209
green extraction technology, 13
green-leaf volatiles, 189
green sea algae species, 376
green seaweeds, 376
green tea extracts, analyzing for polyphenols, 112
guanine, 256
guanosine triphosphate (GTP), 257
guar gum, 280, 280
Gum Arabic. see Acacia gum
Gutika, 71
Gymnema sylvestre, 57
gypenoside XVII, 10
h
Haematococcus pluvialis, 384
Haemophilus influenzae, 321
Hager’s test, 146
hair colorants and dyes, 302
hair cosmeceuticals, 302
hair growth stimulators, 302
Halaven, 386
Halichondria okadai, 386
halichondrin B, 386
Halphen test, 150
harvesting medicinal plants, 90
plant parts and harvesting timing, 91
healthcare system, clinical pharmacognosy in, 423
hemicelluloses, 357
henna. see Lawsone
hennotannic acid. see Lawsone
hepatic fibrosis, 244
heptachlor, 315
herbal anti-diabetic species, 8
herbal-drug interaction, clinical support of, 435–436
herbal drugs, 143, 235, 236
adulteration of, 102–103
qualitative analysis of, 143, 144
quantitative analysis of, 144
herbal excipients, 275
herbal genomics, case studies of, 402, 402
herbal ingredients, adulterants detection in, 114–115
herbal medicinal products (HMP), 434
pharmacognosy relevance in pharmacological
research on, 3
herbal medicine, 1, 101
market potential of, 43–44
standardization using PSMs, 201–202
herbalomics, in crude drugs classification, 35
HES. see hydroxyethyl starch (HES)
hesperetin, 8
Hibiscus sabdariffa, 411
hierarchical cluster analysis (HCA), 181, 339
high-efficiency particulate air filters (HEPA filters), 354
high-performance liquid chromatography (HPLC), 3, 30, 31,
101, 144, 167, 169–171, 215, 219, 334–335, 408

Index 455
analysis of phytoconstituents, 172
chromatogram, 219
in detection and evaluation of adulteration, 112–113
in phytochemical analysis, 157
of Withaferin-A standard and formulation of
Ashwagandhadi lehyam, 170
high-performance liquid chromatography with diode array
detection (HPLC-DAD), 339
high-performance thin-layer chromatography (HPTLC),
9, 169, 173–175
estimation of phytoconstituents and chromatographic
conditions, 176
high-resolution mass spectrometry (HRMS), 11
high-speed countercurrent chromatography
(HSCCC), 225
high thermal efficiency (HTE), 31–32
high throughput analysis (HTA), 32
high-value molecules (HVMs), 376
Hima, 71
histamine-induced broncho constriction in guinea pigs,
240–241
holistic patient care, 34
Holothuroidea, 379
Holothuroidea clade, 379
homeopathy system, 79
history, 79
methods of diagnosis and treatment, 80
principles of, 79–80
homeostasis, 80
Homoeopathic Pharmacopoeia of India (HPI), 97
homologous genes, 401
honey, 320
horseradish (Armoracia rusticana), 22
hot continuous percolation, 128–129
hot maceration process/digestion, 131–132, 132
hot percolation, 128
hot plate method, 249–250, 249
Huangqi Guizhi Wuwu Decoction (HGWD), 410
Human Genome Project, 256
human serum albumin, 276
humours (Uyir thathukkal), 76
hyaluronic acid (HA), 302–303, 372
hybridization, 32
Hydrastis canadensis, 435–436
hydration, 303
hydrilla (Hydrilla spp.), 318
hydro distillation, disadvantages of, 129
hydro steam distillation, 130
advantages of hydro and steam distillation over hydro
distillation, 130
disadvantages of hydro and steam distillation over water
distillation, 130
hydrochloric acid (HCl), 216
hydrodiffusion, 129
hydrogenation, 263
hydrolases, 260
hydrolysable tannins, 335, 191
hydroxy acids, 303
hydroxyethyl starch (HES), 283
hydroxyethylation, 283
7-hydroxymitragynine, 112
hydroxypropyl methylcellulose (HPMC), 278
hydroxypropyl starch (HPS), 283
hydroxypropylation, 283
Hygiene, Perfume, Cosmetics, and Sanitizing Products
Management (GHCOS), 307
hymenialdisine, 385
hyoscine, 59
Hyoscyamus Niger, 19
hyperforin, 425
hyperhydricity, 350
Hypericum perforatum. see St. John’s Wort
(Hypericum perforatum)
hyphenated strategy, 225
hyphenated techniques, 113, 180–181
gas chromatography-mass spectrometry, 113–114
liquid chromatography-mass spectrometry, 114
i
iaaH gene, 365
iaaM gene, 365
Ilaj-Bil-Dawa (pharmacotherapy), 74
Ilaj-Bil-Tadbeer (regimental therapy), 74
Ilaj-Bil-Yad (surgical therapy), 74
Illicium anisatum. see Chinese star anise (Illicium anisatum)
imbibition, 127
imli. see tamarind gum (Tamarindus indica L.)
immobilization methods, 360
immobilized cell culture, 356
IMMU-110. see dolastatin 10
immune system support, 300
immunoenzyme test-systems, 146
immunoglobulins (Ig), 319
immunomodulatory diseases, screening models for, 247
acute-systemic anaphylaxis in rats, 247
immunomodulatory effects, of plant secondary metabolites,
197–198
India, medicinal plant use in, 2
Indian Ayurvedic system, 44
Indian dates. see tamarind gum (Tamarindus indica L.)
Indian traditional medicine. see Ayurvedic medicine
indirect gene transfer methods, 364–365
indirect organogenesis, 355, 355
indirect sonicator, 135, 136
individualization, 79–80
indole-3-acetic acid (IAA), 352
indole acetonitrile, 352
indole-3-butyric acid, 352
Indonesian Food and Drug Administration, 101
induced fusion, 358
inductively coupled plasma mass spectrometry (ICP MS),
30, 30

456 Index
industrially important pharmaceutical aids, 275
Acacia gum, 275, 275
agar-agar, 275–276, 276
albumin, 276
alginates, 276–277
anthocyanidins, 277
cellulose, 277, 277
chitosan, 278
cochineal, 278–279
curcumin, 279
gelatin, 279
gellan gum, 279–280
guar gum, 280
inulin, 281
Karaya gum, 280
Lawsone, 281
locust bean gum, 281–282
pectins, 282, 282
starch, 282–283
tragacanth gum, 280–281, 281
xanthan gum, 283–284
inflammation, 310, 58–59
inflammatory marker assays, 411
inflammatory polyarthritis, 242
infrared spectroscopy (IR spectroscopy), 4, 29, 144, 336
in phytochemical analysis, 158
ingestible skincare. see nutricosmetics
inhibitory concentrations 50 (IC50), 251
inhibitory concentrations 90 (IC90), 251
inorganic nutrients, 349
macronutrients, 350
insect growth regulators (IGRs), 88
insect pheromones, 318
Insecta, 333
insect-based anti-allergens, 319
insect-based biopesticides, 318
Insecticides Act, The, 1968, 326
in situ conservation, 405
integrated pest management programs (IPM programs), 316
Intellectual Property Rights, 28
intermediates, 262–263
internal standardization, 180
International Code of Botanical Nomenclature (ICBN), 4
International Code of Nomenclature for Algae, Fungi, and
Plants (ICN), 18
International Pharmaceutical Excipients Councils
(IPEC), 273
inter-simple sequence repeat (ISSR), 12, 399
intertidal zones, 372
inulin, 281
in vitro cell cultures, 195
in vitro models, 251
culture methods, 251
enzyme inhibition and receptor binding assay, 252
germplasm conservation, 359–360
isolated organs, 251
tissue culture, 349
in vitro toxicity assays, 411
in vivo models, 235
analgesic activity, screening models for, 249–250
anti-inflammatory activity, screening models for, 248–249
antipyretic activity, screening models for, 250
cancer, screening models for, 246–247
cardiovascular system diseases, screening models for,
236–238
dermal diseases, screening models for, 250–251
digestive system diseases, screening models for, 243–245
immunomodulatory diseases, screening models for, 247
metabolic diseases, screening models for, 245–246
musculoskeletal diseases, screening models for, 242–243
nervous system diseases, screening models for, 238–240
ophthalmic diseases, screening models for, 247–248
respiratory system diseases, screening models for, 240–241
urinary system diseases, screening models for, 241–242
in vivo toxicity studies, 411
iodine (I), 350–351
test, 149
value for fixed oils and waxes, 155
iodine value test, 150
ion-exchange chromatography, 219
ionic liquids (ILs), 124, 214
extraction with, 214–215
ionotropic gelation, 276
iposide, 3
iridoid glycosides, 22
irinotecan, 3
Iris, 337
Iris bungei, 338
Iris lactea, 338
Iris tenuifolia, 338
iron (Fe), 350–351
irrigation
affecting medicinal plant cultivation, 86–87
of cultivated medicinal plants, 90
Isatis tinctoria, 404
isocorynantheidine, 112
isoflavones, 309
isolated organs, 251
isolation of intermediates, 261
isoleucine, 268–269
isomerases, 260
isomerization, 263
isopentenyladenine (iP), 353
isopentenyl diphosphate (IPP), 263–264, 266, 270
isopimpinellin, 337
isoprenaline (ISO), 238
isoprenaline-induced myocardial infraction, 238
isoprenoids, 267, 268
intermediates, 270, 271
isoquinoline alkaloids, 337
isorhamnetin, 338

Index 457
isoschaftoside, 339
isothiocyanates, 309
glycosides, 22
isotope dilution analysis, 180
isotopes, 259
isovitexin, 339
j
Japanese flower shikimi, 265
Japanese Kampo Medicine, 28
Japanese star anise. see Japanese flower shikimi
k
Kaempferia galangal (ginger), 303
kaempferol, 8
kaempferol-3-O-glucoside, 339
Kalka, 71
kaolin clay, 318
Kapha dosha, 68–69
kapham, 76
Karaya gum, 280
Kava Kava (Piper methysticum), 436
Kefir, 300
Keller-Killiani test, 146–147
Kerria lacca. see Kwatha Churna
2-keto-3-deoxy-7-phosphoglucoheptonic acid, 265
keto-enol tautomerism, 263
ketones, 263
Kickxia aegyptiaca (L.), 4
kimchi, 300
kinetic maceration, 126
kinetin, 352–353
Kingdom Plantae, 18
Kjeldahl method, protein determination by, 154
Kovacs test, 150
Kratom (Mitragyna speciosa), 112
alkaloids’ quantification in, 112–113
Krebs cycle. see citric acid cycle
Kwatha Churna, 71
l
lac insect (Kerria lacca), 25
lactate dehydrogenase (LDH), 322
Lactobacillus, 320
Lactobacillus rhamnosus GG, 320
ladybugs, 88
Laminaria hyperborea, 276
Lanolin, 301
laser ablation inductively coupled plasma mass spectrometry
(LA-ICP-MS), 30
latex, 259
Law of Minimum Dose, 79
Law of Similar, 79
Law of Single Remedy, 79
Lawsone, 281
Lawsonia inermis, 281
leaching process, 92–93
lead acetate test, 148
leaf culture, 358
leaves used for medicinal purposes, 20
left border (LB), 365
left coronary artery ligation method, 237
Lemna minor. see duckweed (Lemna minor)
Lepa, 72
Leptosphaeria oraemaris, 383
letrozole-induced polycystic ovarian syndrome in female rats,
245–246, 245
leucine, 268–269
L-glutamate, 257
Liber Magnae Collectionis Simplicum Alimentorum Et
Medicamentorum (Baitar), 2
licorice (Glycyrrhiza glabra), 20, 427
lifestyle disorders, 298
ligases, 260
lignans, 23, 192, 200, 341–342
in crude drugs, 22
Lignarenone B, 379
Limniris, 337–338
linear regression analysis, 181
lipid, 149–150, 256, 257
biosynthesis, 260
lipoic acid, 309
lipophilic allergens, 430
liposomes, 310
5-lipoxygenase (5-LOX), 248
lipoxygenases (LO), 201
liquid chromatography (LC), 113, 219, 334
liquid chromatography–electrospray ionization–tandem mass
spectrometry (LC–ESI–MS/MS), 171
liquid chromatography-mass spectrometry (LC-MS), 3, 112,
144, 408
applications in phytochemical analysis, 180–181
authentication of Ginkgo biloba extract using, 114
in phytochemical analysis, 158
liquid chromatography-nuclear magnetic resonance-mass
spectroscopy (LC-NMR-MS), 180
for comprehensive structural elucidation, 181
liquid–liquid chromatography (LLC), 217
liquid–liquid fractionation, 216
liquorice (Glycyrrhiza glabra), 22
Lissoclinum patella, 383
Lithospermum erythrorhizon, 322
L-lysine, 257
locust bean gum, 281–282
Lonchocarpus utilis, 322
London Pharmacopeia in 1618, 395
loperamide, 7
lovastatin, 43
low-density lipoprotein (LDL-C), 309
low-methoxy pectin, 282
Lowry method, protein determination by, 154–155
Lowry protein assay, 150

458 Index
lurbinectedin, 386
lutein, 309
lyases, 260
lycopene, 308, 376
Lyngbya lagerhaimanii, 375
Lyngbya majuscule, 375
Lysimachia baviensis, 338
lysine, 335
m
maceration, 124, 126, 127, 209–210
machine learning (ML)
in crude drugs classification, 35
role in crude drugs, 34
macroalgae, 376, 382–383
Macrocystis pyrifera, 276
macromorphological authentication, 5
macromorphological characters of plant, 5
macronutrients, 350
macrophage chemostatic protein (MCP-1), 200
macroscopic identification, of plant, 4
Madagascar periwinkle plant (Catharanthus roseus (L.)),
7, 212
magnesium (Mg), 350
magnetic resonance imaging (MRI), 159
Maillard method, 424
malaria treatment, Artemisia annua for, 35
Malas, 69
malondialdehyde (MDA), 191, 241, 323
malonyl-CoA, 262, 264, 270
malvidin, 277
manganese (Mn), 350
mangiferin, 322
mangrove forests, 372
manures
of cultivated medicinal plants, 90
in plant nutrition, 87
marine algae
bioactive compounds and applications, 376–378
diversity of marine macroalgae, 375–376
and medicinal potential, 375
marine bacteria, 383
marine-based anti-allergens, 319
marine-based biopesticides, 318
marine biodiversity, ecosystem services provided by, 373
marine compounds, 372
collecting and processing of, 380
marine-derived compounds
anticancer properties of marine compounds, 382–384
neuroprotective and neuropharmacological effects, 384–385
pharmacological activities of, 382
marine-derived hydrogels, 372
marine ecosystems, 372–373
marine environments
biodiversity in, 372–373
microbial diversity in, 374
marine fungi, 383
marine invertebrates, 378
bioactive compounds from, 380
echinoderms, 379–380
molluscs, 379
sponges, 378
marine macroalgae, 376
diversity of, 375–376
marine microorganisms, 318
aplidin, 386
bioactive compounds from, 373
bryostatin-1, 386
dolastatin 10, 386
halaven, 386
lurbinectedin, 386
preclinical and clinical studies of, 385–386
squalamine, 386
marine natural products (MNPs), 378
advancements in marine natural product research, 388
marine organisms, 371
adaptations and survival strategies, 373
for bioactive compounds, 371
drug discovery, importance in, 371–372
marine pharmacognosy, 371
analytical tools and technologies, 382
bioactive compounds, exploring marine organisms for, 371
bioactive compounds from marine microorganisms,
373–375
drug discovery, importance of marine organism in,
371–372
extraction process and characterization techniques,
380–382
future prospects, 388
marine algae and medicinal potential, 375–378
marine ecosystems and biodiversity, 372–373
marine invertebrates, 378–380
marketed marine drug product, 386, 387
pharmacological activities of marine-derived compounds,
382–385
preclinical and clinical studies of marine microorganisms,
385–386
marine pigments, 319
marine plants, 382
macroalgae, 382–383
microalgae, 383
marine polysaccharides, 319
marine proteins, 319
marinosomes, 310
marker-assisted selection (MAS), 406
marketed marine drug product, 386, 387
market trends and consumer preferences, 311
Marrubium vulgare, 57
mass propagation, 405
mass spectrometry (MS), 11, 30, 31, 144, 179, 224, 264, 167,
334, 336, 371, 374, 382, 407, 431
adulterants detection in herbal ingredients, 114–115

Index 459
MS-based plant metabolomics study, 409
in phytochemical analysis, 158
quality control measures for phytochemicals, 180
quantitative analysis for phytochemicals, 179–180
structural elucidation of phytochemicals by, 179
mass spectrometry imaging (MSI), 158
mass-to-charge ratio (m/z ratio), 382, 408
matrix-assisted laser desorption/ionization (MALDI), 382
Mayer’s test, 146
Meat Food Products Order of 1973, 306
mechanical fusion, 358
mechanical method, protoplast isolation, 357
mechanical shearing method, 362
medicinal herbs
establishment of fingerprint profiles, 109–110
evaluation of, 107
microscopic analysis, 108–109
molecular genetic basis for economic features of, 401–402
morphological analysis, 108
multiple marker-based fingerprint profiles for adulterants
detection, 110–111
organoleptic analysis, 109
qualitative and quantitative of phytochemical for
contaminants detection, 109
taxonomic deciding adulteration of medicinal plants,
107–108
medicinal plants, 43–44
adulteration in, 106–107
anticancer activity, 49–57
antidiabetic activity, 57
anti-inflammatory activity, 58–59
antiviral activity, 58
biological activity of, 49
biotechnology, 347
cultivation, 83–85
ethnomedicinal plants used in folk practices, 50–56
gastrointestinal disorders, 57–58
genetic engineering, 362–364
good agricultural practice, 88–91
good collection practices for, 91–92
growing conditions for plants, 94–96
metabolomics in medicinal plant research, 407–408
molecular biosynthesis and metabolomics of, 407
molecular genetics and genomics of, 399–404
permissible levels of contaminants under GAP and GFCP,
98–99
plant tissue culture, 347–362
processing of, 92–93
respiratory disorders, 58
sample record for cultivated medicinal plants, 94
selection, 89
storage and packaging, 93–94
VCSMPP in Indian scenario, 97–99
Melia azedarach L., 4
meristematic cells, 347
Mesopotamia region, medicinal plant use in, 2
MetaboAnalyst, 408
metabolic diseases, screening models for, 245
letrozole-induced polycystic ovarian syndrome in female
rats, 245–246, 245
streptozotocin-induced diabetes in rats, 245
metabolic engineering techniques, 13
metabolic intermediates, 257
metabolic profiling method, 396
metabolism, 259
metabolite profiling techniques, 11
metabolomics, 11, 182, 396, 407
in crude drugs classification, 35
techniques and analytical tools, 408–410
metal-chelating proteins, 299
Metarhizium anisopliae, 318
MetExplore, 408
Metformin, 7
7-methoxylated flavonoids, 338
methoxylation, 282
1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine
(MPTP), 384
mevalonate, 262, 264
MI. see myocardial infarction (MI)
microalgae, 375, 383
microbial assays, 410
microbial diversity, in marine environment, 374
microbial interactions, 13
Micrococcus luteus, 310
microinjection, 364
micronutrients, 350–351
microorganism-based anti-allergens, 320–321
microorganism-based biopesticides, 318–319
microprojectile bombardment/gene gun, 364
micropropagation, 355
microscopy, in detection and evaluation of herbal
adulteration, 111
microwave-aided extraction, 171
microwave-assisted extraction (MAE), 121, 136–138, 209, 213,
381–382
microwave-assisted hydrodistillation, 138
microwave cavity, 137
microwave generator, 137
mid-infrared spectroscopy (MIR), 8
milk thistle (Silybum marianum), 7, 427
Millon’s test, 150
mind–body connection in beauty, 305
Minerae, 333
mineral-based crude drugs, 25
minerals, 299
Ministry of Health, 305, 307
mitochondrial function assays, 411
mitogen-activated protein kinases (MAPK), 248, 322
mitragynine, 112
mitraphylline, 112
Mizaj, 73
mobilizing genes (mob genes), 363

460 Index
modern analytical techniques, 167, 168–169
advantages and challenges of, 31–32
in classification, 29
DNA barcoding, 31
use of advanced analytical methods, 29–31
modern extraction methods, 125
modern pharmacognosy, 3
modern pharmacology, 33
modified legal’s test, 147
modified maceration, 126, 209
moisturization, 303
moisturizers, 303
molecular biology techniques, 256, 395
DNA extraction, polymerase chain reaction, sequencing,
and cloning, 397
molecular markers, barcodes, and databases, 398–399, 399
in pharmacognosy, 396, 398–399
significance, 397–398
molecular biosynthesis and metabolomics
applications and benefits of metabolomics, 408
medicinal plant research, importance and application of
metabolomics in, 407–408
of medicinal plants, 407, 407
metabolomics techniques and analytical tools, 408–410
molecular docking studies, 411
molecular genetics and genomics of medicinal plants, 399
genetics, 403–404
genome duplication, 401
genome evolution, 401
herbal genomics, case studies of, 402, 402
medicinal herbs, molecular genetic basis for economic
features of, 401–402
transcriptome analysis, 402
molecular imaging techniques, 182
molecular markers, barcodes, and databases, 398–399, 399
molecular pharmacognosy, 395, 422. see also clinical
pharmacognosy
bioassays, 410
current trends in, 396
history and evolution of, 395–396
in vitro toxicity assays, 411
in vivo toxicity studies, 411
molecular biology techniques in pharmacognosy, 396–399
molecular biosynthesis and metabolomics of medicinal
plants, 407–410
molecular genetics and genomics of medicinal plants,
399–404
molecular pharmacology and toxicology of medicinal
plants, 410–413
pharmacodynamics, pharmacokinetics, and clinical
trials, 411
phytochemical analysis, 410
plant-derived drugs, mechanism of action, efficacy, and
toxicity of, 412–413
PTC of medicinal plants, 404–407
receptor binding studies, 410–411
risk assessment, 412
safety pharmacological studies, 412
scope and objectives, 396
and toxicology of medicinal plants, 410
Molisch’s test, 149, 150
molluscs, 379, 379
molybdenum (Mo), 350–351
Momordica charantia, 57
Monocots, 18
Monocotyledons, 18
monoterpenes, 335
Montana, 19
Moraxella catarrhalis, 321
morphine, 1, 309
morphological classification, of plants, 19
division based on plant parts used for medicinal purposes,
20–21
examination of macroscopic and microscopic
characteristics, 21
Morris water maze test, 239
mouse tail model for psoriasis, 250–251
multilocus banding patterns, 12
multimode MAE, 137, 137
multi-omics integration, in crude drugs classification, 35
multiple maceration, 209
multiple marker-based fingerprint profiles, for adulterants
detection, 110–111
multitargeted approaches, 11–12
multivariate analysis techniques, 181–182
multivariate chromatographic fingerprint, 182
Murashige and Skoog medium (MS medium), 352
musculoskeletal diseases, screening models for, 242
collagen type-II-induced arthritis in rats, 242–243
ovariectomy-induced osteoporosis in female rats, 243
muskgrass (Chara spp.), 318
mustard (Sinapis alba), 26
mycosporine-like amino acids (MAAs), 377
myocardial infarction (MI), 237
myricetin, 8
myristicin, 201
MZmine, 408
n
Nagoya Protocol, 28, 380
naked plant cell, 357
n-alkyl glycoside derivatives, 341
Nannochloropsis oculata, 377
NaOH test, 148
Nardostachys grandiflora, 340
naringenin, 8, 198
naringin, 198
National Institute of Standards and Technology Mass Spectral
database (NIST-MS database), 179
National Medical Products Administration (NMPA), 307
National Medicinal Plant Board (NMPB), 97
Native American healing, 101
Соседние файлы в папке Библиотека им академика М.И. Перельмана
